Status:
COMPLETED
Prospective Analysis of Incidence and Risk Factors of Infection of Midline Catheter
Lead Sponsor:
Groupe Hospitalier Mutualiste de Grenoble
Collaborating Sponsors:
TIMC-IMAG
Vygon GmbH & Co. KG
Conditions:
Intravascular Device
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Midline catheter is a peripherally-inserted catheter, with the distal tip being placed at or below the level of the axilla. It is a relevant alternative to other catheters in case of limited venou...
Eligibility Criteria
Inclusion
- Age superior or equal to 18 years old
- Intravascular treatment planned for more than 6 days
Exclusion
- Medical history of mastectomy with bilateral lymphadenectomy
- Peripheral neuropathy
- Upper-Extremity Deep Vein Thrombosis
- Arteriovenous fistula
- Poor condition of the skin of the upper limbs
- Patient in palliative care
- Patient in emergency care
- Patient under guardianship/curatorship
- Pregnant or breastfeeding women
Key Trial Info
Start Date :
January 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 21 2019
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT03373630
Start Date
January 16 2018
End Date
October 21 2019
Last Update
December 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Mutualiste de Grenoble
Grenoble, France, 38028